Details of the Drug

General Information of Drug (ID: DMUS9CO)

Drug Name

AV-7909

Indication

Disease Entry	ICD 11	Status	REF
Anthrax	1B97	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01770743) A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels. U.S. National Institutes of Health.